ZA909302B - Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses - Google Patents

Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses

Info

Publication number
ZA909302B
ZA909302B ZA909302A ZA909302A ZA909302B ZA 909302 B ZA909302 B ZA 909302B ZA 909302 A ZA909302 A ZA 909302A ZA 909302 A ZA909302 A ZA 909302A ZA 909302 B ZA909302 B ZA 909302B
Authority
ZA
South Africa
Prior art keywords
immunogens
prophylaxis
against human
viral agents
retroviral particles
Prior art date
Application number
ZA909302A
Other languages
English (en)
Inventor
Omar K Haffar
K Haffar Omar
Shiu-Lok Hu
Hu Shiu-Lok
Allen W Senear
W Senear Allen
Bruce M Travis
M Travis Bruce
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of ZA909302B publication Critical patent/ZA909302B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA909302A 1989-11-20 1990-11-20 Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses ZA909302B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20

Publications (1)

Publication Number Publication Date
ZA909302B true ZA909302B (en) 1991-09-25

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909302A ZA909302B (en) 1989-11-20 1990-11-20 Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses

Country Status (14)

Country Link
EP (1) EP0502105A4 (fi)
JP (1) JPH05503629A (fi)
KR (1) KR920703639A (fi)
AU (1) AU636944B2 (fi)
CA (1) CA2068713A1 (fi)
ES (1) ES2052478T1 (fi)
FI (1) FI922277A0 (fi)
GR (1) GR930300005T1 (fi)
HU (1) HUT60506A (fi)
NO (1) NO921969L (fi)
OA (1) OA09698A (fi)
TW (1) TW216446B (fi)
WO (1) WO1991007425A1 (fi)
ZA (1) ZA909302B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2198400T3 (es) * 1989-06-01 2004-02-01 Applied Biotechnology, Inc. Vector que codifica particulas virales no autopropagantes, defectuosas, auto-ensambladas.
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (de) * 1991-07-26 1993-01-28 Basf Ag Waessrige polymerisatdispersionen
EP1136562A3 (en) * 1991-11-08 2003-06-25 PHARMACIA & UPJOHN COMPANY Feline leukemia virus vaccines
AU2462392A (en) * 1992-04-14 1993-11-18 British Biotech Pharmaceuticals Limited Induction of CTL responses
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
AU675702B2 (en) 1993-01-26 1997-02-13 Leslie R. Coney Compositions and methods for delivery of genetic material
ATE420193T1 (de) * 1993-01-26 2009-01-15 Univ Pennsylvania Zusammensetzung zur verabreichung genetischen materials
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
EP0817854A2 (en) * 1995-03-31 1998-01-14 Wolf, Hans, Prof. Dr. Antigen presentation system based on retrovirus-like particles
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
AU2596600A (en) 1998-12-31 2000-07-31 Chiron Corporation Modified hiv env polypeptides
CA2358385C (en) 1998-12-31 2013-08-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP2388015A1 (en) 2000-03-02 2011-11-23 Emory University DNA expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
AU2002252199B2 (en) 2001-03-08 2008-01-03 Emory University MVA expressing modified HIV envelope, GAG, and POL genes
EP1411770A4 (en) 2001-07-05 2006-05-10 Chiron Corp POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP3173096A1 (en) 2011-04-06 2017-05-31 Biovaxim Limited Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
TW201718638A (zh) 2015-07-21 2017-06-01 現代治療公司 傳染病疫苗
WO2018170270A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Varicella zoster virus (vzv) vaccine
US11752206B2 (en) 2017-03-15 2023-09-12 Modernatx, Inc. Herpes simplex virus vaccine
EP3938379A4 (en) * 2019-03-15 2023-02-22 ModernaTX, Inc. HIV RNA VACCINE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
JP3140757B2 (ja) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
CA2067778A1 (en) * 1989-10-16 1991-04-17 The Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor

Also Published As

Publication number Publication date
ES2052478T1 (es) 1994-07-16
TW216446B (fi) 1993-11-21
EP0502105A1 (en) 1992-09-09
EP0502105A4 (en) 1993-02-24
GR930300005T1 (fi) 1993-04-28
NO921969D0 (no) 1992-05-19
OA09698A (en) 1993-08-30
CA2068713A1 (en) 1991-05-21
WO1991007425A1 (en) 1991-05-30
NO921969L (no) 1992-06-26
AU636944B2 (en) 1993-05-13
JPH05503629A (ja) 1993-06-17
AU6905591A (en) 1991-06-13
HU9201659D0 (en) 1992-08-28
FI922277A (fi) 1992-05-19
KR920703639A (ko) 1992-12-18
FI922277A0 (fi) 1992-05-19
HUT60506A (en) 1992-09-28

Similar Documents

Publication Publication Date Title
ZA909302B (en) Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses
GB2204237B (en) Agents for the prophylaxis and therapy of retroviral infections
EP0330496A3 (en) Skin treatment composition
GB8807246D0 (en) Therapeutic agents
RU1833139C (ru) Akapицидhoe cpeдctbo b фopme эmульгиpуemoгo kohцehtpata
GB8812597D0 (en) Therapeutic agents
IL96404A0 (en) Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses
GB2236675B (en) Cosmetic weight reduction treatment
GB2203645B (en) Improvements in the treatment of hair
GB8812596D0 (en) Therapeutic agents
GB8804531D0 (en) Skin treatment formulations
ZA891894B (en) Composition for the treatment of osteoporosis in humans
GB8804016D0 (en) Therapeutic agents
GB2220652B (en) Treatment of pastures
GB8918242D0 (en) Preparation of agents for use in therapy
ZA882667B (en) Agents for the prophylaxis and therapy of retroviral infections
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
GB8812145D0 (en) Therapeutic agents
GB8801759D0 (en) Therapeutic agents
GB8801758D0 (en) Therapeutic agents
GB2208599B (en) Oral anti-malarial treatment
ZM7288A1 (en) Treatment of diseases caused by retroviruses
SG4695G (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases
GB8818556D0 (en) Novel therapeutic immunoconjugates for use in treatment of cancer
GB8827618D0 (en) Treatments of immunodeficiency